BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24246340)

  • 1. Splenic sarcoidosis without focal nodularity: a case of 1,25-dihydroxyvitamin D-mediated hypercalcemia localized with FDG PET/CT.
    Dennis BA; Jajosky RP; Harper RJ
    Endocr Pract; 2014 Feb; 20(2):e28-33. PubMed ID: 24246340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcoid-like granulomatous myositis-associated hypercalcemia. An infrequent case to consider.
    Uslar T; Olmos R; Godoy-Santin J; Mellado P; Gonzalez G
    Medicina (B Aires); 2021; 81(3):462-466. PubMed ID: 34137710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Rare Case of Extra-Pulmonary Sarcoidosis With Only Initial Presentation of Hypercalcemia.
    Surpur S; Singh A; Webb J
    Cureus; 2023 Sep; 15(9):e45100. PubMed ID: 37842373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Oral Cinacalcet in Non-PTH Nonmalignant Hypercalcemia from Excess 1,25-Dihydroxyvitamin D.
    Mohan S; Sheehan M; Tebben P; Wermers R
    JCEM Case Rep; 2024 Mar; 2(3):luae022. PubMed ID: 38476635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoidosis initially manifesting as symptomatic hypercalcemia with the absence of organic involvement.
    Motoyama K; Inaba M; Emoto M; Morii H; Nishizawa Y
    Intern Med; 2002 Jun; 41(6):449-52. PubMed ID: 12135177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
    Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF
    J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated Muscular Sarcoidosis Revealed by Hypercalcemia and 18F-FDG PET/CT.
    Dhomps A; Foret T; Streichenberger N; Skanjeti A; Tordo J
    Clin Nucl Med; 2019 Oct; 44(10):824-825. PubMed ID: 31274562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life-Threatening Hypercalcemia Revealing Diffuse and Isolated Acute Sarcoid-Like Myositis: A New Entity? (A Case-Series).
    Mageau A; Rigolet A; Benali K; Chauchard M; Ladjeroud S; Mahe I; Maisonobe T; Chauveheid MP; Papo T; Sacre K
    Medicine (Baltimore); 2016 Mar; 95(10):e3089. PubMed ID: 26962842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone-related protein: an unusual mechanism for hypercalcemia in sarcoidosis.
    Krikorian A; Shah S; Wasman J
    Endocr Pract; 2011; 17(4):e84-6. PubMed ID: 21550945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of sarcoidosis-associated hypercalcemia with ketoconazole.
    Bia MJ; Insogna K
    Am J Kidney Dis; 1991 Dec; 18(6):702-5. PubMed ID: 1962657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcoidosis within a pituitary adenoma.
    Rubin MR; Bruce JN; Khandji AG; Freda PU
    Pituitary; 2001 Aug; 4(3):195-202. PubMed ID: 12138993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D.
    Falk S; Kratzsch J; Paschke R; Koch CA
    Med Sci Monit; 2007 Nov; 13(11):CS133-136. PubMed ID: 17968303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET/CT: prevalence and disease pattern.
    Chowdhury FU; Sheerin F; Bradley KM; Gleeson FV
    Clin Radiol; 2009 Jul; 64(7):675-81. PubMed ID: 19520211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages.
    Hewison M; Kantorovich V; Liker HR; Van Herle AJ; Cohan P; Zehnder D; Adams JS
    J Bone Miner Res; 2003 Mar; 18(3):579-82. PubMed ID: 12619944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D-mediated hypercalcemia in multicentric Castleman's disease.
    Tanaka KI; Kanazawa I; Miyake H; Yano S; Amano C; Ishikawa N; Maruyama R; Sugimoto T
    J Bone Miner Metab; 2017 Jan; 35(1):122-125. PubMed ID: 26597827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
    Tebben PJ; Singh RJ; Kumar R
    Endocr Rev; 2016 Oct; 37(5):521-547. PubMed ID: 27588937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated 1,25-dihydroxyvitamin D levels: occurrence with sarcoidosis with end-stage renal disease.
    Maesaka JK; Batuman V; Pablo NC; Shakamuri S
    Arch Intern Med; 1982 Jun; 142(6):1206-7. PubMed ID: 6896430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-Dihydroxyvitamin D-mediated hypercalcemia in oleogranulomatous mastitis (paraffinoma), ameliorated by glucocorticoid administration.
    El Muayed M; Costas AA; Pick AJ
    Endocr Pract; 2010; 16(1):102-6. PubMed ID: 19625241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercalcemia due to endogenous overproduction of 1,25-dihydroxyvitamin D in Crohn's disease.
    Bosch X
    Gastroenterology; 1998 May; 114(5):1061-5. PubMed ID: 9558297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.